Illumina
Illumina, Inc. is globally recognized as the undisputed leader in next-generation sequencing (NGS) and the core technological engine powering NGS-based RNA-sequencing. Its sophisticated sequencing platforms, notably the NovaSeq and NextSeq series, provide the high-throughput, precision, and scalability necessary for complex transcriptomics studies. RNA-sequencing relies fundamentally on these platforms to accurately sequence cDNA derived from RNA, enabling researchers to perform high-resolution gene expression profiling, discover novel transcripts, and analyze complex splicing patterns. Illumina’s integrated ecosystem includes not only the sequencers but also optimized library preparation kits, such as those for total RNA and low-input samples, along with comprehensive bioinformatics software for data analysis. This end-to-end workflow, often using reversible dye-terminator chemistry, makes complex genetic analysis accessible and reliable for academic, pharmaceutical, and clinical labs worldwide. By continually pushing the boundaries of sequencing accuracy and cost-effectiveness, Illumina maintains its transformative impact on genomics research and the rapidly expanding field of RNA analysis, solidifying its position as a giant in the industry.
Latest Market Research Report on NGS-based RNA-sequencing Download PDF Brochure Now
Thermo Fisher Scientific
Thermo Fisher Scientific is a globally renowned provider of scientific solutions and a major player in the NGS-based RNA-sequencing market, primarily through its Ion Torrent platform technology. The company specializes in delivering advanced, user-friendly solutions tailored for various applications, including low-input and challenging RNA samples. A key offering is the Ion AmpliSeq Transcriptome Solution, which provides a specialized kit and protocol for low-input RNA sequencing, ensuring high data integrity and reproducibility even with minimal sample quantities. This technology simplifies the workflow from sample preparation to data analysis, making high-quality RNA analysis accessible to a broader range of laboratories. Furthermore, Thermo Fisher’s commitment extends to offering extensive reagents, kits, and software that support the entire transcriptomics workflow, from RNA isolation to final data interpretation. By focusing on simplified, integrated, and reliable NGS solutions, Thermo Fisher empowers researchers and clinicians to accelerate drug discovery, diagnostics development, and fundamental biological research involving gene expression and RNA biology.
BGI Genomics
BGI Genomics is a formidable global contender in the sequencing services market, playing a significant role in NGS-based RNA-sequencing by offering high-volume and cost-effective solutions. As one of the world’s largest genomics organizations, BGI operates high-throughput sequencing labs that make comprehensive genomic analysis, including transcriptome studies, accessible to researchers globally. Their proprietary BGISEQ-500 platform is particularly renowned for its cost-effectiveness and high data quality, which makes high-throughput RNA-sequencing projects more feasible for large-scale studies. BGI provides a range of sequencing services suitable for diverse RNA applications, from whole transcriptome sequencing to small RNA analysis. The company focuses on minimizing costs while maintaining strong data integrity, supported by a global presence and robust customer services. This dedication to scalability and affordability allows BGI to support a wide range of research initiatives, from large population genomics projects to detailed transcriptomics studies in oncology and rare diseases, securing its position as a key global service provider.
Oxford Nanopore Technologies
Oxford Nanopore Technologies is revolutionizing the NGS-based RNA-sequencing field with its unique, real-time sequencing platform, which offers distinct advantages for transcriptome analysis. The company’s technology is based on passing nucleic acids through nanopores, allowing for sequencing without the need for PCR amplification or synthetic template generation, making it particularly advantageous for low-input RNA sequencing. A key differentiator is its ability to produce ultra-long reads, which provides a more comprehensive, end-to-end view of transcripts, including full-length isoforms and complex splicing events, that is often missed by shorter-read technologies. Furthermore, the technology enables real-time data analysis, significantly speeding up the research process and allowing for immediate decision-making. By offering fast, accessible, and portable sequencing devices, Oxford Nanopore Technologies is democratizing access to complex RNA-sequencing applications, allowing scientists to perform advanced transcriptomics in various settings, from fundamental research labs to decentralized diagnostics.
QIAGEN
QIAGEN is a prominent global provider of sample and assay technologies, with a strong commitment to delivering integrated solutions for NGS-based RNA-sequencing, particularly for challenging and low-input samples. The company’s expertise lies in simplifying complex molecular biology workflows, ensuring high-quality and reliable results from minimal starting material. Their portfolio includes the QIAseq UPX RNA sequencing solutions, which are specifically designed for low-input scenarios, focusing on efficient sample preservation, library preparation, and high data accuracy. QIAGEN provides a comprehensive, integrated approach that spans from initial sample preparation—a critical step in any RNA-sequencing project—to subsequent library construction and sophisticated bioinformatics analysis. By offering robust and user-friendly kits, combined with extensive customer support and training, QIAGEN empowers researchers to maximize their data’s potential in diverse transcriptomics applications, including gene expression analysis and the study of non-coding RNAs, making it an attractive partner for laboratories adopting NGS technologies.
Lexogen
Lexogen is a specialized company recognized for its deep expertise in RNA biology and for providing expert NGS Services specifically tailored for RNA-sequencing solutions. The company distinguishes itself by focusing entirely on the transcriptome, offering a hands-on, consultative approach to various complex RNA analysis projects. Lexogen’s comprehensive NGS services portfolio includes Whole Transcriptome Sequencing, Small RNA Sequencing, FFPE RNA Sequencing, and Single-cell RNA Sequencing, catering to a wide range of research needs. Their proprietary library preparation methods are designed to maximize data quality and capture efficiency, especially for degraded or low-quantity samples. With almost two decades of experience, Lexogen has solidified its position as a leading NGS service provider, driving remarkable successes for customers in biotherapeutics and fundamental research. By offering tailored services and deep domain knowledge, Lexogen serves as a critical partner for researchers who require reliable, high-quality, and specialized RNA-sequencing data.
Latest Market Research Report on NGS-based RNA-sequencing Download PDF Brochure Now